fluticasone propionate nasal
Selected indexed studies
- Allergic Rhinitis: A Review. (JAMA, 2024) [PMID:38470381]
- Fluticasone Propionate Suppresses Poly(I:C)-Induced ACE2 in Primary Human Nasal Epithelial Cells. (Front Cell Infect Microbiol, 2021) [PMID:33981629]
- Treatment of seasonal allergic rhinitis with fluticasone propionate aqueous nasal spray: review of comparator studies. (Allergy, 1995) [PMID:7604951]
_Worker-drafted node — pending editorial review._
Connections
fluticasone propionate nasal is a side effect of
Sources
- Allergic Rhinitis: A Review. (2024) pubmed
- Fluticasone Propionate Suppresses Poly(I:C)-Induced ACE2 in Primary Human Nasal Epithelial Cells. (2021) pubmed
- Treatment of seasonal allergic rhinitis with fluticasone propionate aqueous nasal spray: review of comparator studies. (1995) pubmed
- Onset of therapeutic effect of fluticasone propionate aqueous nasal spray. (2001) pubmed
- Effect of fluticasone propionate on human nasal fibroblasts exposed to urban particulate matter. (2020) pubmed
- Nasal immune gene expression in response to azelastine and fluticasone propionate combination or monotherapy. (2022) pubmed
- Fluticasone propionate nasal spray is more effective and has a faster onset of action than placebo in treatment of rhinitis medicamentosa. (1997) pubmed
- Fluticasone propionate downregulates nasal fibroblast functions involved in airway inflammation and remodeling. (2002) pubmed
- The efficiency of azelastine hydrochloride and fluticasone propionate nasal spray to improve PAP adherence in patients with obstructive sleep apnea. (2025) pubmed
- Fluticasone propionate suppresses the SARS-CoV-2 induced increase in respiratory epithelial permeability in vitro. (2023) pubmed